Leukemia inhibitory factor (LIF), a member of the interleukin-6 cytokine family, regulates the neuronal phenotype and coordinates astrocyte, oligodendrocyte, microglia, and inflammatory cell responses. The LIF gene is located on 22q12.1-q12.2, a hot spot for schizophrenia. Three polymorphisms of the LIF gene (rs929271, rs737812, and rs929273) were examined in a case-control association study of 390 patients with schizophrenia and 410 age-and sex-matched controls. Effects of a risk genotype of LIF on cognitive domains were evaluated by the Wechsler Adult Intelligence Scale-Revised, Wechsler Memory Scale-Revised, and Wisconsin Card Sorting Test (WCST) in 355 healthy volunteers. The LIF gene showed significant associations with schizophrenia at rs929271 and a haplotype consisting of rs929271-rs737812. After stratification by subtype of schizophrenia, the hebephrenic, but not paranoid, type was associated with the LIF gene at rs929271 (allele, P = 0.014) and the haplotype (permutation P = 0.013). Having the T-allele and T-carrier genotypes (TT and TG) of rs929271 were risks for hebephrenic schizophrenia, and the odds ratios were 1.38 (95% CI: 1.21-1.56) and 1.54 (95%CI: 1.19-1.98), respectively. Subjects with T-carrier genotypes made significantly more errors on the WCST compared with those without (P = 0.04). The present study indicated that the LIF gene variant may produce susceptibility to hebephrenic schizophrenia and deterioration of working memory function.
Introduction
Schizophrenia is a severe and complex psychiatric disease characterized by disruption of basic perceptual, cognitive, affective, and judgmental processes, with a lifetime risk of about 1%, and the disorder occurs as a result of interaction between genetic and environmental factors, particularly during the embryological development period. Epidemiological research has indicated that maternal exposure to infection during pregnancy, which induce inflammatory cytokines and activate their signaling cascades, is associated with an increased risk of offspring developing schizophrenia (Brown et al., 2004; Brown, 2008) . Analysis of cerebral spinal fluid and serum has revealed altered levels of certain cytokines in schizophrenic patients (Akiyama, 1999; Toyooka et al., 2003) , and such changes are considered to be involved in regulating brain development and leading to later perceptual and cognitive alterations (Borrell et al., 2002; Fatemi et al., 2008; Meyer et al., 2008; Nawa et al., 2000; Romero et al., 2008; Tohmi et al., 2004; Urakubo et al., 2001) .
Leukemia inhibitory factor (LIF) is a member of the interleukin (IL)-6 cytokine family comprising IL-6, oncostatin M, IL-11, ciliary neurotropic factor, and cardiotropin-1; it signals via binding to a heterodimeric glycoprotein 130 (gp130)/LIF receptor (LIFR) complex (Taga and Kishimoto, 1997). Besides classical hematopoietic effects, LIF was found to regulate neuronal phenotype and coordinate astrocyte, oligodendrocyte, microglia, and inflammatory cell responses (Holmberg and Patterson, 2006; Kerr and Patterson; 2004 , 2005 Sugiura et al., 2000) . LIF signaling activates the Janus kinase-signal transducer and activator of transcription (JAK/STAT) pathways and induces differentiation of neural precursor cells into astrocytes (Barnabe-Heider et al., 2005; Bonni et al., 1997; He et al., 2005) . LIF knock-out (KO) mice display reduced astrocyte and microglial activation in the hippocampus (Holmberg and Patterson, 2006) , and LIF-treated rats display increased glial fibrillary acidic protein (GFAP) immunoreactivity, a cytoskeletal marker of astrocyte, in the neocortex (Watanabe et al., 2004) . The LIF knock-out mice displayed abnormal prepulse inhibition (PPI) in the acoustic startle test during and after adolescence, which is considered as one of the intermediate phenotypes observed in schizophrenic patients (Watanabe et al., 2004 
